Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Frelinger

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Experimental Medicine|February 1, 1976
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cellsJ E Niederhuber, J A Frelinger, M S Dine, et al.
Clinical Immunology (Orlando, Fla.)|October 3, 2001
Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic miceU M Abdel-Motal, R Friedline, B Poligone, et al.
Immunity|May 1, 1996
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTLA L Peace-Brewer, L G Tussey, M Matsui, et al.
Cancer Research|April 15, 1997
A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytesJ S Serody, M E Brecher, G Dent, et al.
Science (New York, N.Y.)|March 20, 1992
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient miceD Muller, B H Koller, J L Whitton, et al.
Vaccine|August 26, 1999
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacyI J Caley, M R Betts, N L Davis, et al.
Blood|December 24, 1998
Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrierJ S Serody, D N Cook, S L Kirby, et al.
European Journal of Immunology|June 1, 1992
A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytesR J Moots, N L Samberg, L Pazmany, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 geneB S Schepart, H Takahashi, K M Cozad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like proteinR C Jambou, J N Snouwaert, G A Bishop, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Experimental Medicine|February 1, 1976
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cellsJ E Niederhuber, J A Frelinger, M S Dine, et al.
Clinical Immunology (Orlando, Fla.)|October 3, 2001
Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic miceU M Abdel-Motal, R Friedline, B Poligone, et al.
Immunity|May 1, 1996
A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTLA L Peace-Brewer, L G Tussey, M Matsui, et al.
Cancer Research|April 15, 1997
A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytesJ S Serody, M E Brecher, G Dent, et al.
Science (New York, N.Y.)|March 20, 1992
LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient miceD Muller, B H Koller, J L Whitton, et al.
Vaccine|August 26, 1999
Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacyI J Caley, M R Betts, N L Davis, et al.
Blood|December 24, 1998
Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrierJ S Serody, D N Cook, S L Kirby, et al.
European Journal of Immunology|June 1, 1992
A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytesR J Moots, N L Samberg, L Pazmany, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
The nucleotide sequence and comparative analysis of the H-2Dp class I H-2 geneB S Schepart, H Takahashi, K M Cozad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
High-level expression of a bioengineered, cysteine-free hepatocyte-stimulating factor (interleukin 6)-like proteinR C Jambou, J N Snouwaert, G A Bishop, et al.
Pageof 17